A.M. Vali

473 total citations
10 papers, 389 citations indexed

About

A.M. Vali is a scholar working on Biomaterials, Oncology and Molecular Biology. According to data from OpenAlex, A.M. Vali has authored 10 papers receiving a total of 389 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Biomaterials, 5 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in A.M. Vali's work include Nanoparticle-Based Drug Delivery (6 papers), Cancer therapeutics and mechanisms (3 papers) and Drug Transport and Resistance Mechanisms (2 papers). A.M. Vali is often cited by papers focused on Nanoparticle-Based Drug Delivery (6 papers), Cancer therapeutics and mechanisms (3 papers) and Drug Transport and Resistance Mechanisms (2 papers). A.M. Vali collaborates with scholars based in Iran and United Kingdom. A.M. Vali's co-authors include Simin Dadashzadeh, Seyed Nasser Ostad, Azadeh Haeri, Bijan Shafaghi, Anna Kelsey, Michael A. Clarke, Fariba Johari Daha and Farzad Kobarfard and has published in prestigious journals such as Journal of Controlled Release, International Journal of Pharmaceutics and Journal of Pharmaceutical and Biomedical Analysis.

In The Last Decade

A.M. Vali

10 papers receiving 378 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A.M. Vali Iran	9	179	164	66	65	63	10	389
J. Roux France	13	105 0.6×	150 0.9×	64 1.0×	61 0.9×	82 1.3×	26	576
Lei Tian China	11	80 0.4×	104 0.6×	24 0.4×	53 0.8×	42 0.7×	37	373
Otto Soepenberg Netherlands	9	109 0.6×	184 1.1×	160 2.4×	43 0.7×	24 0.4×	14	339
E. M. Molnar Hungary	12	164 0.9×	203 1.2×	295 4.5×	57 0.9×	129 2.0×	43	735
Jibin Guan China	12	156 0.9×	230 1.4×	53 0.8×	123 1.9×	79 1.3×	29	501
Vaibhav Rajoriya India	9	65 0.4×	82 0.5×	39 0.6×	27 0.4×	49 0.8×	22	297
Joseph M. Grindel United States	11	51 0.3×	134 0.8×	41 0.6×	34 0.5×	32 0.5×	22	439
Guiling Li China	12	42 0.2×	61 0.4×	27 0.4×	35 0.5×	68 1.1×	16	333
Kuan-Boone Tan Singapore	8	117 0.7×	218 1.3×	47 0.7×	79 1.2×	35 0.6×	10	397

Countries citing papers authored by A.M. Vali

Since Specialization

Citations

This map shows the geographic impact of A.M. Vali's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.M. Vali with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.M. Vali more than expected).

Fields of papers citing papers by A.M. Vali

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A.M. Vali. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.M. Vali. The network helps show where A.M. Vali may publish in the future.

Co-authorship network of co-authors of A.M. Vali

This figure shows the co-authorship network connecting the top 25 collaborators of A.M. Vali. A scholar is included among the top collaborators of A.M. Vali based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A.M. Vali. A.M. Vali is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Haeri, Azadeh, et al.. (2012). Preparation and characterization of valspodar loaded nanoliposomes as a potential adjuvant therapy for drug-resistant tumors. Research in Pharmaceutical Sciences. 7(5). 243. 1 indexed citations

Haeri, Azadeh, et al.. (2012). Co-delivery of Doxorubicin and PSC 833 (Valspodar) by Stealth Nanoliposomes for Efficient Overcoming of Multidrug Resistance. Journal of Pharmacy & Pharmaceutical Sciences. 15(4). 568–568. 48 indexed citations

Dadashzadeh, Simin, et al.. (2010). Peritoneal retention of liposomes: Effects of lipid composition, PEG coating and liposome charge. Journal of Controlled Release. 148(2). 177–186. 100 indexed citations

Vali, A.M., et al.. (2009). Effect of liposome size on peritoneal retention and organ distribution after intraperitoneal injection in mice. International Journal of Pharmaceutics. 383(1-2). 7–13. 67 indexed citations

Vali, A.M., et al.. (2008). Preparation, Optimization, and Characterization of Topotecan Loaded PEGylated Liposomes Using Factorial Design. Drug Development and Industrial Pharmacy. 34(1). 10–23. 26 indexed citations

Vali, A.M., et al.. (2008). 99mTc-HMPAO-labeled liposomes: an investigation into the effects of some formulation factors on labeling efficiency and in vitro stability. Nuclear Medicine and Biology. 35(3). 387–392. 16 indexed citations

Dadashzadeh, Simin, et al.. (2007). The effect of PEG coating on in vitro cytotoxicity and in vivo disposition of topotecan loaded liposomes in rats. International Journal of Pharmaceutics. 353(1-2). 251–259. 53 indexed citations

Vali, A.M., et al.. (2005). Simple and sensitive high performance liquid chromatographic method for the simultaneous quantitation of the lactone and carboxylate forms of topotecan in human plasma. Journal of Chromatography B. 818(2). 205–212. 23 indexed citations

Dadashzadeh, Simin, et al.. (2002). LC determination of piroxicam in human plasma. Journal of Pharmaceutical and Biomedical Analysis. 28(6). 1201–1204. 43 indexed citations

10.

Vali, A.M., Michael A. Clarke, & Anna Kelsey. (1993). Dysembryoplastic neuroepithelial tumour as a potentially treatable cause of intractable epilepsy in children. Clinical Radiology. 47(4). 255–258. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact